SCHEMBL24623936

SCHEMBL24623936

c1ccc2c(c1)ccc1cc(Nc3ccc4c(c3)oc3ccccc34)ccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DUSP3 P51452 1/20 0.53
KMT2A Q03164 7/20 0.49
MEN1 O00255 6/20 0.49
ALDH1A1 P00352 5/20 0.49
HPGD P15428 4/20 0.49
KDM4E B2RXH2 4/20 0.49
MAPT P10636 3/20 0.49
SMN1; SMN2 Q16637 6/20 0.48
NPC1 O15118 6/20 0.48
RAB9A P51151 6/20 0.48
GAA P10253 3/20 0.48
LMNA P02545 3/20 0.47
HTT P42858 2/20 0.47
EPHX2 P34913 1/20 0.47
AHR P35869 1/20 0.46
HSD17B10 Q99714 3/20 0.46
TP53 P04637 3/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25734936 0.94 DUSP3 (0.53) DUSP3KMT2AMEN1ALDH1A1HPGD
SCHEMBL29450788 0.92 EPHX2 (0.55) DUSP3KMT2AMEN1ALDH1A1HPGD
SCHEMBL17742553 0.92 EPHX2 (0.55) DUSP3KMT2AMEN1ALDH1A1HPGD
SCHEMBL24624528 0.90 DUSP3 (0.50) DUSP3KMT2AMEN1ALDH1A1HPGD
SCHEMBL17283499 0.88 KMT2A (0.60) DUSP3KMT2AMEN1ALDH1A1HPGD
SCHEMBL17740520 0.86 ALDH1A1 (0.41) DUSP3KMT2AMEN1ALDH1A1HPGD
SCHEMBL24703067 0.85 ALDH1A1 (0.48) DUSP3KMT2AMEN1ALDH1A1HPGD
SCHEMBL17641246 0.84 DUSP3 (0.51) DUSP3KMT2AMEN1ALDH1A1HPGD
SCHEMBL17382564 0.84 TDP1 (0.43) DUSP3KMT2AMEN1ALDH1A1HPGD
SCHEMBL19533724 0.84 ALDH1A1 (0.59) DUSP3ALDH1A1HPGDMAPTEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220223794-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND APPLICATION THEREOF Wuhan Tianma Microelectronics Co., Ltd. Shanghai Branch (CN) 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223794-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND APPLICATION THEREOF NR0B2, FPR3, NPR3 DUSP3 2623/4885KMT2A 3303/4885MEN1 1937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.